Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

NCT02219009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Mental Disorder
Nervous System Diseases

Interventions

DEVICE: MIND1 System

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.